Val
—
Gro
—
Qua
—
Mom
—
Sta
—
Cap—
P/S0.33
P/E—
Fwd P/E12.58
PEG0.30
52W— – —
RSI—
Target$112.19 (+5.9%)
Beta0.60
Div2.43%
Loading chart…
RSI (14)
Loading patterns…
CVS Health Corporation provides health solutions in the United States. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental, and behavioral health plans; medical management capabilities; Medicare Advantage and Medicare Supplement plans; prescription drug plans (PDPs); and Medicaid health care management services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, specialty and mail-order pharmacy, clinical services, disease management, medical spend management services, and pharmacy and other administrative services. It serves employers, insurance companies, unions, government employee groups, health plans, PDPs, Medicaid managed care plans, CMS, plans offered on public health insurance exchanges, and other sponsors of health benefit plans. The Pharmacy & Consumer Wellness segment sells prescription and over-the-counter drugs, consumer health and beauty products, personal care products, and other general merchandise products. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. It operates online retail pharmacy websites, retail specialty pharmacy stores, and compounding pharmacies, as well as branches for infusion and enteral nutrition services. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1963 and is headquartered in Woonsocket, Rhode Island.
52-Week Range
52W Low
—
52W High
Position in Range
—
RSI (14)
0 · Oversold
RSI 54
Overbought · 100
Signal
Neutral
EMA Price Levels
Volume Analysis
Momentum Dashboard
Trend Strength
Detected Patterns
4Bullish
0Bearish
0Neutral
▲ Bull Flag — Breakout after +13% pole — bullish continuation
▲ Bull Flag — Breakout after +20% pole — bullish continuation
▲ Bull Flag — Breakout after +12% pole — bullish continuation
▲ Bull Flag — Breakout after +16% pole — bullish continuation
View overlays on the price chart via Chart tab → Pattern Overlays.
EPS — History & Forecast
Estimate
Beat
Miss
Forecast
Loading…
Revenue — History & Forecast
Revenue
Forecast
Loading…
EPS Beat Rate
88%
7/8 quarters
Wall Street Consensus
STRONG BUY
BuyHoldSell
Price Target Range
$112.19
+5.9% upside
Low $79
—
High $148
Consensus
Current price
Wall Street Analyst Ratings
| Firm | Rating | Change | Action | Date |
|---|---|---|---|---|
| UBS | Buy | — | ↔ Maintain | 2026-07-25 |
| Truist Securities | Buy | — | ↔ Maintain | 2026-07-14 |
| Wells Fargo | Overweight | — | ↔ Maintain | 2026-07-13 |
| RBC Capital | Outperform | — | ↔ Maintain | 2026-07-09 |
| Cantor Fitzgerald | Overweight | — | ↔ Maintain | 2026-07-07 |
| B of A Securities | Buy | — | ↔ Maintain | 2026-06-23 |
| Mizuho | Outperform | — | ↔ Maintain | 2026-06-08 |
| Morgan Stanley | Overweight | — | ↔ Maintain | 2026-06-04 |
| Barclays | Overweight | — | ↔ Maintain | 2026-05-26 |
| Bernstein | Outperform | — | ↔ Maintain | 2026-05-13 |
| JP Morgan | Overweight | — | ↔ Maintain | 2026-05-12 |
| TD Cowen | Buy | — | ↔ Maintain | 2026-05-11 |
| Evercore ISI Group | Outperform | — | ↔ Maintain | 2026-05-07 |
| Baird | Outperform | — | ↔ Maintain | 2026-04-15 |
| Piper Sandler | Overweight | — | ↔ Maintain | 2026-03-31 |
| Argus Research | Buy | — | ↔ Maintain | 2026-01-28 |
UBS
2026-07-25
Buy
↔ Maintain
Truist Securities
2026-07-14
Buy
↔ Maintain
Wells Fargo
2026-07-13
Overweight
↔ Maintain
RBC Capital
2026-07-09
Outperform
↔ Maintain
Cantor Fitzgerald
2026-07-07
Overweight
↔ Maintain
B of A Securities
2026-06-23
Buy
↔ Maintain
Mizuho
2026-06-08
Outperform
↔ Maintain
Morgan Stanley
2026-06-04
Overweight
↔ Maintain
Barclays
2026-05-26
Overweight
↔ Maintain
Bernstein
2026-05-13
Outperform
↔ Maintain
JP Morgan
2026-05-12
Overweight
↔ Maintain
TD Cowen
2026-05-11
Buy
↔ Maintain
Evercore ISI Group
2026-05-07
Outperform
↔ Maintain
Baird
2026-04-15
Outperform
↔ Maintain
Piper Sandler
2026-03-31
Overweight
↔ Maintain
Argus Research
2026-01-28
Buy
↔ Maintain
Profitability
Gross Margin
13.39%TTM
Op. Margin
4.12%TTM
ROE
3.75%TTM
Rev. Growth
6.10%YoY
Free Cash Flow
5.20BTTM
FCF Yield
—TTM
Balance Sheet
Debt / Equity
100.91MRQ
Current Ratio
0.87MRQ
Cash
11.80BMRQ
Total Debt
78.35BMRQ
Net Debt
—MRQ
Income
Div. Yield
2.43%TTM
Annual Rate
2.66Fwd
Payout Ratio
116.67%TTM
Dividend History
Payout Ratio (TTM): 116.67%
| Date | Amount / Share | Yield at Payment |
|---|---|---|
| 2026-07-23 | $0.6650 | 0.62% |
| 2026-04-23 | $0.6650 | 0.85% |
| 2026-01-22 | $0.6650 | 0.82% |
| 2025-10-23 | $0.6650 | 0.84% |
| 2025-07-22 | $0.6650 | 1.12% |
| 2025-04-22 | $0.6650 | 1.06% |
| 2025-01-23 | $0.6650 | 1.30% |
| 2024-10-21 | $0.6650 | 1.22% |
| 2024-07-22 | $0.6650 | 1.23% |
| 2024-04-19 | $0.6650 | 1.04% |
| 2024-01-19 | $0.6650 | 1.00% |
| 2023-10-19 | $0.6050 | 0.95% |
| 2023-07-20 | $0.6050 | 0.91% |
| 2023-04-20 | $0.6050 | 0.93% |
| 2023-01-19 | $0.6050 | 0.79% |
| 2022-10-20 | $0.5500 | 0.69% |
| 2022-07-21 | $0.5500 | 0.68% |
| 2022-04-21 | $0.5500 | 0.61% |
| 2022-01-20 | $0.5500 | 0.63% |
| 2021-10-21 | $0.5000 | 0.68% |
| 2021-07-22 | $0.5000 | 0.71% |
| 2021-04-22 | $0.5000 | 0.78% |
| 2021-01-21 | $0.5000 | 0.81% |
| 2020-10-21 | $0.5000 | 1.02% |
| 2020-07-22 | $0.5000 | 0.95% |
| 2020-04-22 | $0.5000 | 1.01% |
| 2020-01-22 | $0.5000 | 0.83% |
| 2019-10-23 | $0.5000 | 0.95% |
| 2019-07-24 | $0.5000 | 1.12% |
| 2019-04-22 | $0.5000 | 1.20% |
| 2019-01-24 | $0.5000 | 0.98% |
| 2018-10-23 | $0.5000 | 0.89% |
| 2018-07-24 | $0.5000 | 0.99% |
| 2018-04-20 | $0.5000 | 1.00% |
| 2018-01-23 | $0.5000 | 0.82% |
| 2017-10-23 | $0.5000 | 0.87% |
| 2017-07-20 | $0.5000 | 0.86% |
| 2017-04-19 | $0.5000 | 0.86% |
| 2017-01-20 | $0.5000 | 0.83% |
| 2016-10-20 | $0.4250 | 0.66% |
How CVS Makes Its Money
Cash Flow Breakdown
Quarterly Metrics
| Quarter | Revenue | Rev YoY | Gross Profit | Op. Income | Net Income | Net YoY | Gross % | Op % | Net % |
|---|
Full Key Statistics
Valuation
| Market Cap | 135.15B |
| Enterprise Value | 201.87B |
| Trailing P/E | 47.93 |
| Forward P/E | 12.58 |
| PEG Ratio (5yr) | 0.30 |
| Price/Sales (ttm) | 0.33 |
| Price/Book (mrq) | 1.74 |
| EV/Revenue | 0.50 |
| EV/EBITDA | 13.10 |
Share Statistics
| Avg Vol (3m) | 8.31M |
| Shares Outstanding | 1.28B |
| Float | 1.27B |
| % Held by Insiders | 0.06% |
| % Held by Institutions | 90.32% |
| Short Ratio | 2.47 |
| Short % of Float | 1.54% |
Profitability
| Gross Margin | 13.39% |
| Operating Margin (ttm) | 4.12% |
| Profit Margin | 0.72% |
| Return on Assets (ttm) | 2.67% |
| Return on Equity (ttm) | 3.75% |
Income Statement
| Revenue (ttm) | 405.62B |
| Revenue Growth (yoy) | 6.10% |
| Gross Profit (ttm) | 54.30B |
| EBITDA | 15.41B |
| Net Income (ttm) | 2.93B |
| Diluted EPS (ttm) | 2.21 |
| EPS Growth (yoy) | 63.10% |
Balance Sheet
| Total Cash (mrq) | 11.80B |
| Total Debt (mrq) | 78.35B |
| Debt / Equity (mrq) | 100.91 |
| Current Ratio (mrq) | 0.87 |
| Book Value / Share | 60.84 |
| Operating CF (ttm) | 10.33B |
| Free Cash Flow (ttm) | 5.20B |
Trading & Dividends
| Beta (5Y) | 0.60 |
| 50-Day MA | 100.52 |
| 200-Day MA | 84.16 |
| Fwd Dividend Yield | 243.00% |
| Payout Ratio | 116.67% |
Ownership Breakdown
Institutional 90.32%
Insider 0.06%
Public 9.6%
Short Interest
1.54% of float
Low
Institutional 13F Holdings
Famous investors who disclosed a position in CVS in their latest SEC 13F filing.
Loading…
Insider Transactions
| Date | Insider | Role | Transaction | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-21 | ROBBINS LARRY | Director | Sale at price 93.45 - 96.28 per share. | 3,372,000 | $317,471,136 |
| 2026-05-14 | BALSER JEFFREY R M.D., PH.D. | Director | Stock Award(Grant) at price 97.15 per share. | 2,058 | $199,935 |
| 2026-05-14 | SANSONE GUY P | Director | Stock Award(Grant) at price 97.15 per share. | 1,447 | $140,576 |
| 2026-05-14 | BROWN C DAVID II | Director | Stock Award(Grant) at price 97.15 per share. | 1,544 | $150,000 |
| 2026-05-14 | AGUIRRE FERNANDO | Director | Stock Award(Grant) at price 97.15 per share. | 1,563 | $151,845 |
| 2026-05-14 | NORWALK LESLIE V | Director | Stock Award(Grant) at price 97.15 per share. | 1,447 | $140,576 |
| 2026-05-14 | KIRBY JOHN SCOTT | Director | Stock Award(Grant) at price 97.15 per share. | 1,447 | $140,576 |
| 2026-05-08 | MANDADI TILAK | Officer | Sale at price 89.58 per share. | 69,551 | $6,230,379 |
| 2026-03-31 | COMPTON-PHILLIPS AMY | Officer | Stock Award(Grant) at price 71.82 per share. | 5,569 | $399,966 |
| 2026-03-31 | CLARK JAMES DAVID | Officer | Stock Award(Grant) at price 71.82 per share. | 11,138 | $799,931 |
| 2026-03-31 | NEWMAN BRIAN | Chief Financial Officer | Stock Award(Grant) at price 71.82 per share. | 19,493 | $1,399,987 |
| 2026-03-31 | MANDADI TILAK | Officer | Stock Award(Grant) at price 71.82 per share. | 22,277 | $1,599,934 |
| 2026-03-31 | SHAH PREM S | Officer | Stock Award(Grant) at price 71.82 per share. | 25,062 | $1,799,953 |
| 2026-03-31 | NELSON STEVEN H | Officer | Stock Award(Grant) at price 71.82 per share. | 22,277 | $1,599,934 |
| 2026-03-31 | JOYNER JOHN DAVID | Chief Executive Officer | Stock Award(Grant) at price 71.82 per share. | 86,326 | $6,199,933 |
| 2026-03-31 | KHICHI SAMRAT S | General Counsel | Stock Award(Grant) at price 71.82 per share. | 12,531 | $899,976 |
| 2026-03-31 | CAPOZZI HEIDI B | Officer | Stock Award(Grant) at price 71.82 per share. | 10,025 | $719,996 |
| 2026-03-19 | GALLINA JOHN E | Director | Stock Award(Grant) at price 71.86 per share. | 582 | $41,823 |
| 2025-11-20 | BALSER JEFFREY R M.D., PH.D. | Director | Stock Award(Grant) at price 76.04 per share. | 1,775 | $134,971 |
| 2025-11-20 | FINUCANE ANNE A | Director | Stock Award(Grant) at price 76.04 per share. | 591 | $44,940 |
| 2025-11-20 | BROWN C DAVID II | Director | Stock Award(Grant) at price 76.04 per share. | 1,775 | $134,971 |
| 2025-11-20 | AGUIRRE FERNANDO | Director | Stock Award(Grant) at price 76.04 per share. | 1,800 | $136,872 |
| 2025-11-20 | SANSONE GUY P | Director | Stock Award(Grant) at price 76.04 per share. | 1,652 | $125,618 |
| 2025-11-20 | NORWALK LESLIE V | Director | Stock Award(Grant) at price 76.04 per share. | 1,652 | $125,618 |
| 2025-11-20 | SHULMAN DOUGLAS H | Director | Stock Award(Grant) at price 76.04 per share. | 1,652 | $125,618 |
ROBBINS LARRY
Director
Sale at price 93.45 - 96.28 per share.
2026-05-21
3,372,000 sh
$317,471,136
BALSER JEFFREY R M.D., PH.D.
Director
Stock Award(Grant) at price 97.15 per share.
2026-05-14
2,058 sh
$199,935
SANSONE GUY P
Director
Stock Award(Grant) at price 97.15 per share.
2026-05-14
1,447 sh
$140,576
BROWN C DAVID II
Director
Stock Award(Grant) at price 97.15 per share.
2026-05-14
1,544 sh
$150,000
AGUIRRE FERNANDO
Director
Stock Award(Grant) at price 97.15 per share.
2026-05-14
1,563 sh
$151,845
NORWALK LESLIE V
Director
Stock Award(Grant) at price 97.15 per share.
2026-05-14
1,447 sh
$140,576
KIRBY JOHN SCOTT
Director
Stock Award(Grant) at price 97.15 per share.
2026-05-14
1,447 sh
$140,576
MANDADI TILAK
Officer
Sale at price 89.58 per share.
2026-05-08
69,551 sh
$6,230,379
COMPTON-PHILLIPS AMY
Officer
Stock Award(Grant) at price 71.82 per share.
2026-03-31
5,569 sh
$399,966
CLARK JAMES DAVID
Officer
Stock Award(Grant) at price 71.82 per share.
2026-03-31
11,138 sh
$799,931
NEWMAN BRIAN
Chief Financial Officer
Stock Award(Grant) at price 71.82 per share.
2026-03-31
19,493 sh
$1,399,987
MANDADI TILAK
Officer
Stock Award(Grant) at price 71.82 per share.
2026-03-31
22,277 sh
$1,599,934
SHAH PREM S
Officer
Stock Award(Grant) at price 71.82 per share.
2026-03-31
25,062 sh
$1,799,953
NELSON STEVEN H
Officer
Stock Award(Grant) at price 71.82 per share.
2026-03-31
22,277 sh
$1,599,934
JOYNER JOHN DAVID
Chief Executive Officer
Stock Award(Grant) at price 71.82 per share.
2026-03-31
86,326 sh
$6,199,933
KHICHI SAMRAT S
General Counsel
Stock Award(Grant) at price 71.82 per share.
2026-03-31
12,531 sh
$899,976
CAPOZZI HEIDI B
Officer
Stock Award(Grant) at price 71.82 per share.
2026-03-31
10,025 sh
$719,996
GALLINA JOHN E
Director
Stock Award(Grant) at price 71.86 per share.
2026-03-19
582 sh
$41,823
BALSER JEFFREY R M.D., PH.D.
Director
Stock Award(Grant) at price 76.04 per share.
2025-11-20
1,775 sh
$134,971
FINUCANE ANNE A
Director
Stock Award(Grant) at price 76.04 per share.
2025-11-20
591 sh
$44,940
BROWN C DAVID II
Director
Stock Award(Grant) at price 76.04 per share.
2025-11-20
1,775 sh
$134,971
AGUIRRE FERNANDO
Director
Stock Award(Grant) at price 76.04 per share.
2025-11-20
1,800 sh
$136,872
SANSONE GUY P
Director
Stock Award(Grant) at price 76.04 per share.
2025-11-20
1,652 sh
$125,618
NORWALK LESLIE V
Director
Stock Award(Grant) at price 76.04 per share.
2025-11-20
1,652 sh
$125,618
SHULMAN DOUGLAS H
Director
Stock Award(Grant) at price 76.04 per share.
2025-11-20
1,652 sh
$125,618